Trials / Completed
CompletedNCT05688917
Green Coffee Effect on Metabolic Syndrome
Effect of Green Coffee Supplementation on Inflammatory Biomarkers in Obese Patients With Metabolic Syndrome
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 160 (actual)
- Sponsor
- Tanta University · Academic / Other
- Sex
- All
- Age
- 20 Years – 60 Years
- Healthy volunteers
- Not accepted
Summary
The present study aimed to investigate the effect of green coffee bean extract (GCBE) on the inflammatory biomarkers in obese patients with a metabolic syndrome via analyzing some inflammatory biomarkers as resistin, TNF-α, total sialic acid, homocysteine, high sensitivity C-reactive protein (hs-CRP) and anti-inflammatory cytokine, adiponectin
Detailed description
160 obese patients supplemented with either GCBE capsules (800 mg) daily or placebo for 6 months and advised to take a balanced diet. Blood samples were collected at baseline and after three months of supplementation
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DIETARY_SUPPLEMENT | Green coffee been extract | supportive treatment |
| OTHER | Placebo | Placebo capsule |
Timeline
- Start date
- 2020-09-03
- Primary completion
- 2022-09-01
- Completion
- 2022-09-30
- First posted
- 2023-01-18
- Last updated
- 2023-05-26
Locations
1 site across 1 country: Egypt
Source: ClinicalTrials.gov record NCT05688917. Inclusion in this directory is not an endorsement.